Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Bain-backed Cardurion raises $260M to fund ex-Imara drug, buy more cardio assets
10 months ago
Financing
Startups
After last year's ImmunoGen pact, Vertex finds another conditioning agent partner in Orum
10 months ago
Startups
Deals
German biotech CatalYm raises $150M to repurpose obesity target for cancer
10 months ago
Financing
Vertex takes federal government to court over Casgevy fertility treatment program
10 months ago
Pharma
Law
Alzheimer's biotech Asceneuron raises $100M to see if it can compete with Lilly, Biogen on tau
10 months ago
Financing
Startups
CordenPharma injects €900M to boost GLP-1 manufacturing in US and Europe
10 months ago
Manufacturing
Exclusive: Kins raises $7M to expand in-home and virtual physical therapy
10 months ago
Financing
Startups
Roche details early obesity data from GLP-1/GIP agonist, plans for Phase 2 study this year
10 months ago
R&D
Facing a tepid Alzheimer’s market, Lilly looks to build ‘a sense of urgency’ to jumpstart sales of donanemab
10 months ago
Pharma
J&J calls proposed class action talc suit 'meritless' as settlement vote deadline nears
10 months ago
Pharma
Law
EMA warns patients to tell doctors about GLP-1 usage before surgery
10 months ago
Pharma
FDA+
Revolution Medicines' RAS inhibitor shows promise in early-stage pancreatic cancer trial
10 months ago
R&D
Evofem inks women’s health deal; AusperBio brings in $37M
10 months ago
News Briefing
Updated: Lexeo Therapeutics' gene therapy shows potential for Friedreich's ataxia cardiomyopathy with early data
10 months ago
R&D
Cell/Gene Tx
Artiva aims for $116M in second attempt at IPO to boost NK cell therapy pipeline
10 months ago
Financing
Cell/Gene Tx
GSK HQ officially returns to central London after decades in city’s suburbs
10 months ago
Pharma
Deep dive on pay packages; Lilly strikes $3.2B buyout; Pfizer’s R&D head to depart; and more
10 months ago
Weekly
Lilly says lupus drug dropped from pipeline failed to show efficacy
10 months ago
R&D
Pharma
Indivior axes schizophrenia drug and shrinks revenue guidance
10 months ago
R&D
Pharma
Two healthcare SPACs go public, with several more on the hunt for deals
10 months ago
Financing
Deals
How SCOTUS' decision in Chevron could change the way the FDA regulates biopharma
10 months ago
FDA+
Law
Metagenomi science chief departs, just a few months after IPO
10 months ago
People
Startups
Ideaya raises $302M; AbbVie to seek approval in giant cell arteritis
10 months ago
News Briefing
Spinouts, pension reforms and a GSK vet in cabinet: What the new UK government could mean for life sciences
10 months ago
Financing
Startups
First page
Previous page
123
124
125
126
127
128
129
Next page
Last page